期刊文献+

切割bcl-2 mRNA核酶对人胆管癌细胞致瘤性的影响 被引量:5

Effect of bcl-2 mRNA-cleaving ribozyme on tumorogenicity of cholangioma cells in nude mice
下载PDF
导出
摘要 目的 研究切割 bcl- 2 m RNA核酶对人胆管癌细胞致瘤性的影响 .方法 将合成的切割 bcl- 2 m RNA核酶基因与真核细胞表达载体重组 ,并用重组后的载体转染人胆管癌细胞 ,再将经转染的胆管癌细胞接种于裸鼠皮下 ,观察该肿瘤细胞的致瘤情况 .结果 转染切割 bcl- 2 m RNA核酶基因的胆管癌细胞的 bcl- 2表达水平及裸鼠体内致瘤性 (0 / 5 )较对照组 (8/ 10和 5 / 5 )明显下降 .结论 该切割 bcl- 2 m RNA核酶能明显降低胆管癌细胞内 bcl- AIM To study the effect of bcl-2 mRNA-cleaving ribozyme (RZ) on tumorogenicity of cholangioma cells in nude mice. METHODS Synthesized gene of bcl-2 mRNA-cleaving RZ was recombined with a retroviral vector that can transcribe and express in eukaryotic cells, and transfected into human cholangioma cells, and then the cells were inoculated into subcutaneous tissue of nude mice. Tumorogenicity of the cholangioma cells in nude mice was observed. RESULTS bcl-2 expressing level of transfected cholangioma cells and their tumorogenicity in nude mice were declined evidently (0/5) compared with control groups (8/10 and 5/5). CONCLUSION bcl-2 mRNA-cleaving RZ can cut down bcl-2expressing level of cholangioma cells notably and reduce tumorogenicity of the cells in nude mice.
出处 《第四军医大学学报》 2000年第12期1479-1481,共3页 Journal of the Fourth Military Medical University
关键词 核酶 胆管癌 细胞 致瘤性 BCL-2 MRNA ribozymes cholangioma cell tumorigenicitytests test nude mice
  • 相关文献

参考文献4

二级参考文献9

  • 1皋岚湘,丁华野,邓永江,田玉旺,吴霞.乳腺癌组织bcl-2、P53和c-erbB-2蛋白表达和相互关系及意义[J].中华病理学杂志,1996,25(3):165-168. 被引量:40
  • 2王万忠,王家耀,杜德利.bcl-2癌基因在肝肿瘤的表达[J].中华医学杂志,1996,76(6):470-471. 被引量:23
  • 3唐晓鹏,HaroldJ.James.Bax抗原在艾滋病人脑组织中的表达及其原位检测[J].中华微生物学和免疫学杂志,1996,16(3):187-190. 被引量:9
  • 4Zhao M,Histopathology,1994年,25卷,237页
  • 5Charlotte,F.L'Hermine'A.martin N,et al.Immunohistochemical detection of bcl-2 protein in normal and patholical human liver.Am J Pathol.1994:460.
  • 6Silvestri R.Veneroni S,Daidon MG,et al.The bcl-2 protein:a prognostic indicator strongly related to p53 protein in lymph nodenegative breast cancer patients.I Nati Cancer Inst.1994;86:499.
  • 7Oltval Zn,Milliman CL and korameyer SJ.Bcl-2 heterodimerizes in vivo with a conserved homolog,Bax that accelerates programmed cell death Cell.1993;74:609.
  • 8Krajewski S,Krajewska M.Shabaik A.et al.Immunohistochemical determination of in vivo distribution of Bax,a dominant inhibitor of Bcl-2.Am Pathol.1994;145:1323.
  • 9白庆咸 黄高升 陈协群.Bax 基因在混合细胞型霍奇金病组织中的表达及意义[J].第四军医大学学报,1996,1794:297-297.

共引文献25

同被引文献33

  • 1程晋,胡家露,张学庸,罗金燕.肿瘤基因治疗的核酶策略[J].医学与哲学,1997,18(1):9-11. 被引量:3
  • 2Medina MF;Joshi S.Design,characterization and testing of tRNA3Lys-based hammerhead ribozyme[J],1999(07).
  • 3Klebba C;Ottmann OG;Scherr M.Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+T cells in vitro[J],2000(07).
  • 4Von Weizsacker FV;Blum HE;Wands JR.Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template[J],1992(02).
  • 5Ruiz J;Wu CH;Ito Y.Design and preparation of a multimeric self-cleaving hammerhead ribozyme[J],1997(02).
  • 6Welch PJ;Tritz R;Yei S.Intracellular application of hairpin ribozyme genes against hepatitis B virus[J],1997(04).
  • 7Kobayashi H;Dorai T;Holland JF.Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDRI(PGYI) ribozyme,1994(05).
  • 8汤群辉,王禾,陈宝琦,丛义平,邵国兴,雷芳,王文勇.抗凋亡基因bcl-2在肾癌中的表达与意义[J].第四军医大学学报,1999,20(2):141-142. 被引量:8
  • 9屈艺,欧阳雪松,刘菽秋,彭晓东,刘柏林.核酶抑制端粒酶活性的实验研究[J].中华医学遗传学杂志,1999,16(3):133-137. 被引量:21
  • 10陈义军,章翔,步星耀,王占祥,张旭.人脑胶质瘤Fas和Fas Ligand的表达[J].第四军医大学学报,2000,21(1):80-82. 被引量:12

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部